Mechanism of Yiqi Yangying Heluo Formula in the Treatment of IgA Nephropathy by Affecting Gd-IgA1 Based on BAFF Molecular Level and T Lymphocyte Immunity

Table 4

Effect of Yiqi Yangying Heluo Formula on the levels of IL-4, IL6, and IL-17 in peripheral blood of patients with IgAN ().

Items	HC group	IgAN group
		Before treatment	24 weeks of treatment	48 weeks of follow-up
IL-4 (pg/mL)			^#	^#▲
IL-6 (pg/mL)			^#	^#▲
IL-17 (pg/mL)			^#	^#▲

Note: Compared with the HC group, . ^#Compared with the level before treatment, . ^▲Compared with level at 24 weeks of treatment, .